Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120814297 | 12081429 | 7 | F | 2014 | 20160630 | 20160216 | 20160710 | EXP | PHHY2014CA081779 | NOVARTIS | 59.20 | YR | F | Y | 0.00000 | 20160711 | PH | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120814297 | 12081429 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO | 21008 | 20 | MG | /month | |||||||
| 120814297 | 12081429 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO | 21008 | 30 | MG | /month | |||||||
| 120814297 | 12081429 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 50 MG, QMO | 21008 | 50 | MG | /month | |||||||
| 120814297 | 12081429 | 4 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | 150 UG, BID | Y | 0 | 150 | UG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120814297 | 12081429 | 1 | Insulinoma |
| 120814297 | 12081429 | 4 | Insulinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120814297 | 12081429 | HO |
| 120814297 | 12081429 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120814297 | 12081429 | Asthenia | |
| 120814297 | 12081429 | Blood pressure decreased | |
| 120814297 | 12081429 | Blood pressure diastolic decreased | |
| 120814297 | 12081429 | Cough | |
| 120814297 | 12081429 | Dermatitis allergic | |
| 120814297 | 12081429 | Dizziness | |
| 120814297 | 12081429 | Foot fracture | |
| 120814297 | 12081429 | General physical health deterioration | |
| 120814297 | 12081429 | Heart rate decreased | |
| 120814297 | 12081429 | Hypoglycaemia | |
| 120814297 | 12081429 | Injection site pain | |
| 120814297 | 12081429 | Mania | |
| 120814297 | 12081429 | Pruritus | |
| 120814297 | 12081429 | Rash erythematous | |
| 120814297 | 12081429 | Skin burning sensation | |
| 120814297 | 12081429 | Sleep disorder | |
| 120814297 | 12081429 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120814297 | 12081429 | 1 | 20140627 | 0 | ||
| 120814297 | 12081429 | 4 | 2014 | 0 |